People are vaccinated at the Palais de Congress COVID-19 vaccination clinic, Thursday, May 13, 2021 in Montreal.THE CANADIAN PRESS/Ryan Remiorz

People are vaccinated at the Palais de Congress COVID-19 vaccination clinic, Thursday, May 13, 2021 in Montreal.THE CANADIAN PRESS/Ryan Remiorz

Canadian maker of promising mRNA vaccine looks to test it against Pfizer in new trial

Calgary-based Providence Therapeutics says its vaccine produced no serious adverse events and developed good antibodies against COVID-19

A homegrown mRNA vaccine for COVID-19 shows promising results in its first small trial and its maker is hoping to test it directly against the vaccine from Pfizer-BioNTech.

Calgary-based Providence Therapeutics says its vaccine produced no serious adverse events and developed good antibodies against COVID-19 that “compare favourably” with the two mRNA vaccines already on the market from Pfizer and Moderna.

“We’re extremely pleased,” said Providence CEO Brad Sorenson.

The Phase 1 trial included 60 healthy adults between 18 and 64, with more than half of them receiving two doses of the vaccine, four weeks apart. The results have not yet been peer-reviewed.

Sorenson said the next step is supposed to be a Phase 2 head-to-head trial that would test the effectiveness of Providence against Pfizer. Most vaccines in Phase 2 have been tested only against a placebo, but Sorenson said in a pandemic he feels it is unethical to give someone a placebo when they could otherwise be vaccinated.

But to do the trial, Providence needs 500 doses of Pfizer, which he said neither the company nor the National Research Council has been willing to provide.

A spokeswoman for Pfizer said Thursday the company’s focus is only on getting the vaccine to meet an “urgent public health need” and will only sell its vaccine to the federal government.

“As such, we are not providing supply of our vaccine to third-parties to study the vaccine in comparative trials,” said Christina Antoniou.

Pfizer is the main component of Canada’s vaccination campaign to date, accounting for two-thirds of the deliveries as of this week.

A spokesman for Innovation Minister François-Philippe Champagne said the government has informed Providence Ottawa is willing to help fund its Phase 2 trial, and continue to work with the company.

“Minister Champagne has spoken directly with Providence Therapeutics’ CEO and the chair of their board of directors to discuss our continued support for their work as they bring their vaccine candidate through the early stages of development,” said John Power.

A spokesman for the National Research Council said it doesn’t have access to doses of Pfizer or Moderna to help Providence, but is discussing the request with other departments that might be able to help, including Health Canada and the Public Health Agency of Canada.

Sorenson said Providence is also discussing with the World Health Organization the possibility of doing a Phase 3 trial in a developing country.

Sorenson said if Health Canada supports both trials, they could be wrapped up by the end of the year. But Sorenson said he doesn’t feel supported by Ottawa and has threatened to take the business outside the country.

The company has production agreements in place that should be able to produce 200 million doses a year, he said.

Providence is one of six Canadian companies that received funding from the National Research Council for COVID-19 vaccines that were in early stages of development.

The company received $4.9 million last October to help fund its Phase 1 trial. It also received $5 million in January from the next-generation manufacturing supercluster to help scale up its manufacturing of mRNA.

Canada currently doesn’t make any of the vaccines it is using — Pfizer is being made in Europe and the United States, Canada’s doses of Moderna are all coming from Europe, and Oxford-AstraZeneca is coming from the United States, India and South Korea.

The only Canadian-made vaccine among the seven procured by Canada for COVID-19 to date is Medicago’s plant-based protein vaccine, which is now in a Phase 3 trial and could be ready for mass production before the end of the year.

Medicago received $173 million in October to push its vaccine forward as well as an undisclosed sum for a contract to provide Canada at least 20 million doses if it is approved. Some of it will be made in Canada, but production will also take place in the U.S.

A lack of domestic drug manufacturing hurt Canada’s vaccination program, particularly early on, and Prime Minister Justin Trudeau said the government is intent on fixing that ahead of the next global health crisis.

Like us on Facebook and follow us on Twitter.

Want to support local journalism? Make a donation here.

Coronavirus

Just Posted

The Trail Smoke Eaters will open the 2021 season on Oct. 8 against the Cranbrook Bucks in Cranbrook, and will have their home opener the next night against the same Bucks. Photo: Jack Murray
BC Hockey League announces 54-game schedule to begin in October

Trail Smoke Eaters open season with home-and-home series versus Cranbrook Bucks

Daryl Jolly, his wife Kerry Pagdin, their sons Cole Jolly (left) and Graeme Jolly, and their dogs Gracie and Clover. Photo: Submitted
Selkirk College arts chair diagnosed with lung cancer, family launches fund drive

Daryl Jolly co-founded the college’s digital arts program

TELUS is proposing to construct a 5G tower at Pople Park. Photo: Sheri Regnier
First 5G tower in Trail proposed for placement in popular park

TELUS has a consultation process open until June 28

The Kootenay International Junior Hockey League met for their AGM and announced a number of new initiatives, new awards and changes in their executive committee, as well as the starting date for the 2021-22 season. Paul Rodgers file.
KIJHL announces start dates for 2021-22 season

Season set to begin Oct. 1 with league still following all health guidelines

South Slocan’s Ti Loran is among the recipients of this year’s Neil Muth Memorial Scholarship. Photo: Submitted
Neil Muth Memorial Scholarships awarded to 4 students

Students in Creston, South Slocan and Revelstoke are sharing the honour

People watch a car burn during a riot following game 7 of the NHL Stanley Cup final in downtown Vancouver, B.C., in this June 15, 2011 photo. THE CANADIAN PRESS/Geoff Howe
10 years ago: Where were you during the 2011 Vancouver Stanley Cup Riots?

Smashed-in storefronts, looting, garbage can fires and overturned cars some of the damage remembered today

(Black Press Media file)
Dirty money: Canadian currency the most germ-filled in the world, survey suggests

Canadian plastic currency was found to contain 209 bacterial cultures

(pixabay file shot)
B.C. ombudsperson labels youth confinement in jail ‘unsafe,’ calls for changes

Review states a maximum of 22 hours for youth, aged 12 from to 17, to be placed in solitary

Grace (left), a caribou that was born in a maternal pen north of Revelstoke, is alive and well said the province. It appears she even has a calf. Maternity pens aim to increase caribou calf survival by protecting them from predation until they are older and less vulnerable. (Contributed)
For the first time in years, caribou numbers increasing near Revelstoke

North herd growing but south herd still concerning

Eleonore Alamillo-Laberge, 6, reads a book in Ottawa on Monday, June 12, 2017. THE CANADIAN PRESS/Sean Kilpatrick
Parents will need to fight ‘COVID learning slump’ over summer: B.C. literacy experts

Parents who play an active role in educating their children this summer can reverse the slump by nearly 80%, says Janet Mort

Kelowna General Hospital. (File photo)
COVID-19 outbreak at Kelowna General Hospital declared over

Three people tested positive for the virus — two patients and one staff — one of whom died

The border crossing on Highway 11 in Abbotsford heading south (file)
Western premiers call for clarity, timelines on international travel, reopening rules

Trudeau has called Thursday meeting, premiers say they expect to leave that meeting with a plan

The B.C. government’s vaccine booking website is busy processing second-dose appointments, with more than 76 per cent of adults having received a first dose. THE CANADIAN PRESS/Jonathan Hayward
B.C.’s COVID-19 infections, hospitalizations stable for Tuesday

108 new confirmed cases, 139 in hospital, 39 in intensive care

Most Read